世界の免疫組織化学（IHC）検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Immunohistochemistry (IHC) Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5207 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、免疫組織化学（IHC）検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来式直接法、新直接法、酵素架橋法、PAP法）、用途別市場規模（病院、研究所、企業、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・免疫組織化学（IHC）検査の市場動向 ・企業の競争状況、市場シェア ・免疫組織化学（IHC）検査の種類別市場規模と予測2016-2027（従来式直接法、新直接法、酵素架橋法、PAP法） ・免疫組織化学（IHC）検査の用途別市場規模と予測2016-2027（病院、研究所、企業、その他） ・免疫組織化学（IHC）検査の北米市場規模2016-2027（アメリカ、カナダ） ・免疫組織化学（IHC）検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・免疫組織化学（IHC）検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・免疫組織化学（IHC）検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・免疫組織化学（IHC）検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（University of Texas MD Anderson Cancer Center、Memorial Sloan Kettering Cancer Center、Mayo Clinic、Johns Hopkins Hospital、Cleveland Clinic、Dana-Farber/Brigham and Women's Cancer Center、Cedars-Sinai Medical Center、Northwestern Memorial Hospital、Seattle Cancer Care Alliance/University of Washington Medical Center、University of California San Francisco Medical Center、CancerResearchUK、Pfizer） ・結論

Market Analysis and Insights: Global Immunohistochemistry (IHC) Testing Market
The global Immunohistochemistry (IHC) Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immunohistochemistry (IHC) Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immunohistochemistry (IHC) Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immunohistochemistry (IHC) Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immunohistochemistry (IHC) Testing market.

Global Immunohistochemistry (IHC) Testing Scope and Market Size
Immunohistochemistry (IHC) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunohistochemistry (IHC) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Traditional Direct Method
New Direct Method
Enzyme Bridgemethod
PAP Method

Segment by Application
Hospital
Research Institute
Corporation
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
University of Texas MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Johns Hopkins Hospital
Cleveland Clinic
Dana-Farber/Brigham and Women’s Cancer Center
Cedars-Sinai Medical Center
Northwestern Memorial Hospital
Seattle Cancer Care Alliance/University of Washington Medical Center
University of California San Francisco Medical Center
CancerResearchUK
Pfizer

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunohistochemistry (IHC) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Traditional Direct Method
1.2.3 New Direct Method
1.2.4 Enzyme Bridgemethod
1.2.5 PAP Method
1.3 Market by Application
1.3.1 Global Immunohistochemistry (IHC) Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Corporation
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Immunohistochemistry (IHC) Testing Market Perspective (2016-2027)
2.2 Immunohistochemistry (IHC) Testing Growth Trends by Regions
2.2.1 Immunohistochemistry (IHC) Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immunohistochemistry (IHC) Testing Historic Market Share by Regions (2016-2021)
2.2.3 Immunohistochemistry (IHC) Testing Forecasted Market Size by Regions (2022-2027)
2.3 Immunohistochemistry (IHC) Testing Industry Dynamic
2.3.1 Immunohistochemistry (IHC) Testing Market Trends
2.3.2 Immunohistochemistry (IHC) Testing Market Drivers
2.3.3 Immunohistochemistry (IHC) Testing Market Challenges
2.3.4 Immunohistochemistry (IHC) Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Immunohistochemistry (IHC) Testing Players by Revenue
3.1.1 Global Top Immunohistochemistry (IHC) Testing Players by Revenue (2016-2021)
3.1.2 Global Immunohistochemistry (IHC) Testing Revenue Market Share by Players (2016-2021)
3.2 Global Immunohistochemistry (IHC) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immunohistochemistry (IHC) Testing Revenue
3.4 Global Immunohistochemistry (IHC) Testing Market Concentration Ratio
3.4.1 Global Immunohistochemistry (IHC) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunohistochemistry (IHC) Testing Revenue in 2020
3.5 Immunohistochemistry (IHC) Testing Key Players Head office and Area Served
3.6 Key Players Immunohistochemistry (IHC) Testing Product Solution and Service
3.7 Date of Enter into Immunohistochemistry (IHC) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Immunohistochemistry (IHC) Testing Breakdown Data by Type
4.1 Global Immunohistochemistry (IHC) Testing Historic Market Size by Type (2016-2021)
4.2 Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Type (2022-2027)

5 Immunohistochemistry (IHC) Testing Breakdown Data by Application
5.1 Global Immunohistochemistry (IHC) Testing Historic Market Size by Application (2016-2021)
5.2 Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Immunohistochemistry (IHC) Testing Market Size (2016-2027)
6.2 North America Immunohistochemistry (IHC) Testing Market Size by Type
6.2.1 North America Immunohistochemistry (IHC) Testing Market Size by Type (2016-2021)
6.2.2 North America Immunohistochemistry (IHC) Testing Market Size by Type (2022-2027)
6.2.3 North America Immunohistochemistry (IHC) Testing Market Size by Type (2016-2027)
6.3 North America Immunohistochemistry (IHC) Testing Market Size by Application
6.3.1 North America Immunohistochemistry (IHC) Testing Market Size by Application (2016-2021)
6.3.2 North America Immunohistochemistry (IHC) Testing Market Size by Application (2022-2027)
6.3.3 North America Immunohistochemistry (IHC) Testing Market Size by Application (2016-2027)
6.4 North America Immunohistochemistry (IHC) Testing Market Size by Country
6.4.1 North America Immunohistochemistry (IHC) Testing Market Size by Country (2016-2021)
6.4.2 North America Immunohistochemistry (IHC) Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Immunohistochemistry (IHC) Testing Market Size (2016-2027)
7.2 Europe Immunohistochemistry (IHC) Testing Market Size by Type
7.2.1 Europe Immunohistochemistry (IHC) Testing Market Size by Type (2016-2021)
7.2.2 Europe Immunohistochemistry (IHC) Testing Market Size by Type (2022-2027)
7.2.3 Europe Immunohistochemistry (IHC) Testing Market Size by Type (2016-2027)
7.3 Europe Immunohistochemistry (IHC) Testing Market Size by Application
7.3.1 Europe Immunohistochemistry (IHC) Testing Market Size by Application (2016-2021)
7.3.2 Europe Immunohistochemistry (IHC) Testing Market Size by Application (2022-2027)
7.3.3 Europe Immunohistochemistry (IHC) Testing Market Size by Application (2016-2027)
7.4 Europe Immunohistochemistry (IHC) Testing Market Size by Country
7.4.1 Europe Immunohistochemistry (IHC) Testing Market Size by Country (2016-2021)
7.4.2 Europe Immunohistochemistry (IHC) Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size (2016-2027)
8.2 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Type
8.2.1 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Application
8.3.1 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region
8.4.1 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Immunohistochemistry (IHC) Testing Market Size (2016-2027)
9.2 Latin America Immunohistochemistry (IHC) Testing Market Size by Type
9.2.1 Latin America Immunohistochemistry (IHC) Testing Market Size by Type (2016-2021)
9.2.2 Latin America Immunohistochemistry (IHC) Testing Market Size by Type (2022-2027)
9.2.3 Latin America Immunohistochemistry (IHC) Testing Market Size by Type (2016-2027)
9.3 Latin America Immunohistochemistry (IHC) Testing Market Size by Application
9.3.1 Latin America Immunohistochemistry (IHC) Testing Market Size by Application (2016-2021)
9.3.2 Latin America Immunohistochemistry (IHC) Testing Market Size by Application (2022-2027)
9.3.3 Latin America Immunohistochemistry (IHC) Testing Market Size by Application (2016-2027)
9.4 Latin America Immunohistochemistry (IHC) Testing Market Size by Country
9.4.1 Latin America Immunohistochemistry (IHC) Testing Market Size by Country (2016-2021)
9.4.2 Latin America Immunohistochemistry (IHC) Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size (2016-2027)
10.2 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Type
10.2.1 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Application
10.3.1 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country
10.4.1 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 University of Texas MD Anderson Cancer Center
11.1.1 University of Texas MD Anderson Cancer Center Company Details
11.1.2 University of Texas MD Anderson Cancer Center Business Overview
11.1.3 University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Introduction
11.1.4 University of Texas MD Anderson Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021)
11.1.5 University of Texas MD Anderson Cancer Center Recent Development
11.2 Memorial Sloan Kettering Cancer Center
11.2.1 Memorial Sloan Kettering Cancer Center Company Details
11.2.2 Memorial Sloan Kettering Cancer Center Business Overview
11.2.3 Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Introduction
11.2.4 Memorial Sloan Kettering Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021)
11.2.5 Memorial Sloan Kettering Cancer Center Recent Development
11.3 Mayo Clinic
11.3.1 Mayo Clinic Company Details
11.3.2 Mayo Clinic Business Overview
11.3.3 Mayo Clinic Immunohistochemistry (IHC) Testing Introduction
11.3.4 Mayo Clinic Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021)
11.3.5 Mayo Clinic Recent Development
11.4 Johns Hopkins Hospital
11.4.1 Johns Hopkins Hospital Company Details
11.4.2 Johns Hopkins Hospital Business Overview
11.4.3 Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Introduction
11.4.4 Johns Hopkins Hospital Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021)
11.4.5 Johns Hopkins Hospital Recent Development
11.5 Cleveland Clinic
11.5.1 Cleveland Clinic Company Details
11.5.2 Cleveland Clinic Business Overview
11.5.3 Cleveland Clinic Immunohistochemistry (IHC) Testing Introduction
11.5.4 Cleveland Clinic Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021)
11.5.5 Cleveland Clinic Recent Development
11.6 Dana-Farber/Brigham and Women’s Cancer Center
11.6.1 Dana-Farber/Brigham and Women’s Cancer Center Company Details
11.6.2 Dana-Farber/Brigham and Women’s Cancer Center Business Overview
11.6.3 Dana-Farber/Brigham and Women’s Cancer Center Immunohistochemistry (IHC) Testing Introduction
11.6.4 Dana-Farber/Brigham and Women’s Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021)
11.6.5 Dana-Farber/Brigham and Women’s Cancer Center Recent Development
11.7 Cedars-Sinai Medical Center
11.7.1 Cedars-Sinai Medical Center Company Details
11.7.2 Cedars-Sinai Medical Center Business Overview
11.7.3 Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Introduction
11.7.4 Cedars-Sinai Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021)
11.7.5 Cedars-Sinai Medical Center Recent Development
11.8 Northwestern Memorial Hospital
11.8.1 Northwestern Memorial Hospital Company Details
11.8.2 Northwestern Memorial Hospital Business Overview
11.8.3 Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Introduction
11.8.4 Northwestern Memorial Hospital Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021)
11.8.5 Northwestern Memorial Hospital Recent Development
11.9 Seattle Cancer Care Alliance/University of Washington Medical Center
11.9.1 Seattle Cancer Care Alliance/University of Washington Medical Center Company Details
11.9.2 Seattle Cancer Care Alliance/University of Washington Medical Center Business Overview
11.9.3 Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Introduction
11.9.4 Seattle Cancer Care Alliance/University of Washington Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021)
11.9.5 Seattle Cancer Care Alliance/University of Washington Medical Center Recent Development
11.10 University of California San Francisco Medical Center
11.10.1 University of California San Francisco Medical Center Company Details
11.10.2 University of California San Francisco Medical Center Business Overview
11.10.3 University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Introduction
11.10.4 University of California San Francisco Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021)
11.10.5 University of California San Francisco Medical Center Recent Development
11.11 CancerResearchUK
11.11.1 CancerResearchUK Company Details
11.11.2 CancerResearchUK Business Overview
11.11.3 CancerResearchUK Immunohistochemistry (IHC) Testing Introduction
11.11.4 CancerResearchUK Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021)
11.11.5 CancerResearchUK Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Immunohistochemistry (IHC) Testing Introduction
11.12.4 Pfizer Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021)
11.12.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Immunohistochemistry (IHC) Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Traditional Direct Method
Table 3. Key Players of New Direct Method
Table 4. Key Players of Enzyme Bridgemethod
Table 5. Key Players of PAP Method
Table 6. Global Immunohistochemistry (IHC) Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Immunohistochemistry (IHC) Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Immunohistochemistry (IHC) Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Immunohistochemistry (IHC) Testing Market Share by Regions (2016-2021)
Table 10. Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Immunohistochemistry (IHC) Testing Market Share by Regions (2022-2027)
Table 12. Immunohistochemistry (IHC) Testing Market Trends
Table 13. Immunohistochemistry (IHC) Testing Market Drivers
Table 14. Immunohistochemistry (IHC) Testing Market Challenges
Table 15. Immunohistochemistry (IHC) Testing Market Restraints
Table 16. Global Immunohistochemistry (IHC) Testing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Immunohistochemistry (IHC) Testing Market Share by Players (2016-2021)
Table 18. Global Top Immunohistochemistry (IHC) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunohistochemistry (IHC) Testing as of 2020)
Table 19. Ranking of Global Top Immunohistochemistry (IHC) Testing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Immunohistochemistry (IHC) Testing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Immunohistochemistry (IHC) Testing Product Solution and Service
Table 23. Date of Enter into Immunohistochemistry (IHC) Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immunohistochemistry (IHC) Testing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Type (2016-2021)
Table 27. Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Immunohistochemistry (IHC) Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Application (2016-2021)
Table 31. Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Immunohistochemistry (IHC) Testing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Immunohistochemistry (IHC) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Immunohistochemistry (IHC) Testing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Immunohistochemistry (IHC) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Immunohistochemistry (IHC) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Immunohistochemistry (IHC) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Immunohistochemistry (IHC) Testing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Immunohistochemistry (IHC) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Immunohistochemistry (IHC) Testing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Immunohistochemistry (IHC) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Immunohistochemistry (IHC) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Immunohistochemistry (IHC) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Immunohistochemistry (IHC) Testing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Immunohistochemistry (IHC) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Immunohistochemistry (IHC) Testing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Immunohistochemistry (IHC) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Immunohistochemistry (IHC) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Immunohistochemistry (IHC) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 63. University of Texas MD Anderson Cancer Center Company Details
Table 64. University of Texas MD Anderson Cancer Center Business Overview
Table 65. University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Product
Table 66. University of Texas MD Anderson Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021) & (US$ Million)
Table 67. University of Texas MD Anderson Cancer Center Recent Development
Table 68. Memorial Sloan Kettering Cancer Center Company Details
Table 69. Memorial Sloan Kettering Cancer Center Business Overview
Table 70. Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Product
Table 71. Memorial Sloan Kettering Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021) & (US$ Million)
Table 72. Memorial Sloan Kettering Cancer Center Recent Development
Table 73. Mayo Clinic Company Details
Table 74. Mayo Clinic Business Overview
Table 75. Mayo Clinic Immunohistochemistry (IHC) Testing Product
Table 76. Mayo Clinic Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021) & (US$ Million)
Table 77. Mayo Clinic Recent Development
Table 78. Johns Hopkins Hospital Company Details
Table 79. Johns Hopkins Hospital Business Overview
Table 80. Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Product
Table 81. Johns Hopkins Hospital Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021) & (US$ Million)
Table 82. Johns Hopkins Hospital Recent Development
Table 83. Cleveland Clinic Company Details
Table 84. Cleveland Clinic Business Overview
Table 85. Cleveland Clinic Immunohistochemistry (IHC) Testing Product
Table 86. Cleveland Clinic Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021) & (US$ Million)
Table 87. Cleveland Clinic Recent Development
Table 88. Dana-Farber/Brigham and Women's Cancer Center Company Details
Table 89. Dana-Farber/Brigham and Women's Cancer Center Business Overview
Table 90. Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry (IHC) Testing Product
Table 91. Dana-Farber/Brigham and Women's Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021) & (US$ Million)
Table 92. Dana-Farber/Brigham and Women's Cancer Center Recent Development
Table 93. Cedars-Sinai Medical Center Company Details
Table 94. Cedars-Sinai Medical Center Business Overview
Table 95. Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Product
Table 96. Cedars-Sinai Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021) & (US$ Million)
Table 97. Cedars-Sinai Medical Center Recent Development
Table 98. Northwestern Memorial Hospital Company Details
Table 99. Northwestern Memorial Hospital Business Overview
Table 100. Northwestern Memorial Hospital Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021) & (US$ Million)
Table 101. Northwestern Memorial Hospital Recent Development
Table 102. Seattle Cancer Care Alliance/University of Washington Medical Center Company Details
Table 103. Seattle Cancer Care Alliance/University of Washington Medical Center Business Overview
Table 104. Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Product
Table 105. Seattle Cancer Care Alliance/University of Washington Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021) & (US$ Million)
Table 106. Seattle Cancer Care Alliance/University of Washington Medical Center Recent Development
Table 107. University of California San Francisco Medical Center Company Details
Table 108. University of California San Francisco Medical Center Business Overview
Table 109. University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Product
Table 110. University of California San Francisco Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021) & (US$ Million)
Table 111. University of California San Francisco Medical Center Recent Development
Table 112. CancerResearchUK Company Details
Table 113. CancerResearchUK Business Overview
Table 114. CancerResearchUK Immunohistochemistry (IHC) Testing Product
Table 115. CancerResearchUK Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021) & (US$ Million)
Table 116. CancerResearchUK Recent Development
Table 117. Pfizer Company Details
Table 118. Pfizer Business Overview
Table 119. Pfizer Immunohistochemistry (IHC) Testing Product
Table 120. Pfizer Revenue in Immunohistochemistry (IHC) Testing Business (2016-2021) & (US$ Million)
Table 121. Pfizer Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunohistochemistry (IHC) Testing Market Share by Type: 2020 VS 2027
Figure 2. Traditional Direct Method Features
Figure 3. New Direct Method Features
Figure 4. Enzyme Bridgemethod Features
Figure 5. PAP Method Features
Figure 6. Global Immunohistochemistry (IHC) Testing Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Corporation Case Studies
Figure 10. Other Case Studies
Figure 11. Immunohistochemistry (IHC) Testing Report Years Considered
Figure 12. Global Immunohistochemistry (IHC) Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Immunohistochemistry (IHC) Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Immunohistochemistry (IHC) Testing Market Share by Regions: 2020 VS 2027
Figure 15. Global Immunohistochemistry (IHC) Testing Market Share by Regions (2022-2027)
Figure 16. Global Immunohistochemistry (IHC) Testing Market Share by Players in 2020
Figure 17. Global Top Immunohistochemistry (IHC) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunohistochemistry (IHC) Testing as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Immunohistochemistry (IHC) Testing Revenue in 2020
Figure 19. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Type (2016-2021)
Figure 20. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Type (2022-2027)
Figure 21. North America Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Immunohistochemistry (IHC) Testing Market Share by Type (2016-2027)
Figure 23. North America Immunohistochemistry (IHC) Testing Market Share by Application (2016-2027)
Figure 24. North America Immunohistochemistry (IHC) Testing Market Share by Country (2016-2027)
Figure 25. United States Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Immunohistochemistry (IHC) Testing Market Share by Type (2016-2027)
Figure 29. Europe Immunohistochemistry (IHC) Testing Market Share by Application (2016-2027)
Figure 30. Europe Immunohistochemistry (IHC) Testing Market Share by Country (2016-2027)
Figure 31. Germany Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Immunohistochemistry (IHC) Testing Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Immunohistochemistry (IHC) Testing Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Immunohistochemistry (IHC) Testing Market Share by Region (2016-2027)
Figure 41. China Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Immunohistochemistry (IHC) Testing Market Share by Type (2016-2027)
Figure 49. Latin America Immunohistochemistry (IHC) Testing Market Share by Application (2016-2027)
Figure 50. Latin America Immunohistochemistry (IHC) Testing Market Share by Country (2016-2027)
Figure 51. Mexico Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Immunohistochemistry (IHC) Testing Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Immunohistochemistry (IHC) Testing Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Immunohistochemistry (IHC) Testing Market Share by Country (2016-2027)
Figure 57. Turkey Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Immunohistochemistry (IHC) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. University of Texas MD Anderson Cancer Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2016-2021)
Figure 61. Memorial Sloan Kettering Cancer Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2016-2021)
Figure 62. Mayo Clinic Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2016-2021)
Figure 63. Johns Hopkins Hospital Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2016-2021)
Figure 64. Cleveland Clinic Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2016-2021)
Figure 65. Dana-Farber/Brigham and Women's Cancer Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2016-2021)
Figure 66. Cedars-Sinai Medical Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2016-2021)
Figure 67. Northwestern Memorial Hospital Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2016-2021)
Figure 68. Seattle Cancer Care Alliance/University of Washington Medical Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2016-2021)
Figure 69. University of California San Francisco Medical Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2016-2021)
Figure 70. CancerResearchUK Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---